返回ChemicalBook首页>CAS数据库列表>141064-23-5

141064-23-5

中文名称 诺美林草酸盐
英文名称 3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methylpyridineoxalate
CAS 141064-23-5
分子式 C14H23N3OS.C2H2O4
分子量 371
MOL 文件 141064-23-5.mol
更新日期 2024/06/03 14:41:42
141064-23-5 结构式 141064-23-5 结构式

基本信息

中文别名
草酸占诺美林
诺美林草酸盐
呫诺美林草酸盐
英文别名
Lumeron
LY246708 oxalate
Xanomeline oxalate
Xanomeline oxalate salt
LY246708
MEMCOR
LUMERON
3-(3-Hexyloxy-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine oxalate
3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methylpyridineoxalate
3-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methylpyridine ethanedioate (1:1)

物理化学性质

熔点148-150℃
储存条件Desiccate at +4°C
溶解度DMF: 1.6 mg/ml; DMF:PBS (pH 7.2) (1:9): 0.1 mg/ml
形态粉末

安全数据

危险性符号(GHS)
GHS06
警示词危险
危险性描述H301

常见问题列表

生物活性
Xanomeline oxalate (LY246708 oxalate) 是一种有效的、选择性毒蕈碱受体激动剂 (SMRA),可刺激体内的磷酸肌醇水解。 Xanomeline oxalate 可用于研究阿尔茨海默氏病。
靶点

muscarinic receptor

体外研究

Xanomeline stimulates phosphoinositide (PI) hydrolysis in the A9 L m1 cells.
Xanomeline inhibits [ 3 H]-pirenzepine ([ 3 H]-PZ) and [ 3 H]- oxotremorine -M ([ 3 H]-OXO-M) binding to rat brain with K i s of 7 and 3 nM, respectively.

体内研究

Xanomeline robustly stimulates in vivo PI hydrolysis and the effect is blocked by muscarinic antagonists, demonstrating mediation by muscarinic receptors. In mice the ED 100 for Xanomeline-induced stimulation of [ 3 H]-IP accumulation is 54 μmole/kg in hippocampus. And in rats the ED 100 for Xanomeline-induced stimulation of [ 3 H]-IP accumulation is 8.1 μmole/kg in hippocampus.

Animal Model: Male CF1 mice weighing 18-20 g are injected [ 3 H]-myoinositol
Dosage: 8.1-81 μmole/kg
Administration: S.c. injections; 1 h prior to killing and 1 h after the administration
Result: Increased accumulation in a dose-related manner up to 130%, 75%, 60% above lithium levels in hippocampus, cortex and neostriatum, respectively. And did not increase accumulation of [ 3 H]-IP in the brain stem. Induced salivation, tremor and hypothermia in mice with the ED 50 of 13.7±0.8 μmole/kg.
Animal Model: Rats are injected [ 3 H]-myoinositol
Dosage: 2.7-81 μmole/kg
Administration: S.c. injections; 1 h prior to killing and 1 h after the administration
Result: Increased [ 3 H]-IP formation dose dependently in hippocampus up to 221% above lithium control.
"141064-23-5" 相关产品信息